Meghan Larin

Meghan Larin is a Senior Scientist and Gene and Cell Editing Specialist at AstraZeneca, where they currently work. They previously served as a Research Associate at the UK Dementia Research Institute from 2019 to 2022 and held a postdoctoral research fellowship at The Francis Crick Institute from 2015 to 2019. Meghan completed their PhD in Pharmacology and Toxicology at the University of Toronto and has experience as a Teaching Assistant there. Their educational background also includes an MSc in Biomedical Sciences and Toxicology from the University of Guelph and a BSc in Honours Biochemistry from the University of Waterloo.